1. Home
  2. CUBI vs AMPH Comparison

CUBI vs AMPH Comparison

Compare CUBI & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Customers Bancorp Inc

CUBI

Customers Bancorp Inc

HOLD

Current Price

$73.75

Market Cap

2.5B

Sector

Finance

ML Signal

HOLD

Logo Amphastar Pharmaceuticals Inc.

AMPH

Amphastar Pharmaceuticals Inc.

HOLD

Current Price

$25.67

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CUBI
AMPH
Founded
1994
1996
Country
United States
United States
Employees
790
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
1.3B
IPO Year
2012
2014

Fundamental Metrics

Financial Performance
Metric
CUBI
AMPH
Price
$73.75
$25.67
Analyst Decision
Buy
Buy
Analyst Count
7
6
Target Price
$84.14
$31.00
AVG Volume (30 Days)
291.5K
374.8K
Earning Date
01-22-2026
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
4.96
2.27
Revenue
$651,983,000.00
$723,305,000.00
Revenue This Year
$16.77
$1.35
Revenue Next Year
$6.91
$5.10
P/E Ratio
$14.71
$11.14
Revenue Growth
N/A
N/A
52 Week Low
$40.75
$20.39
52 Week High
$73.94
$45.39

Technical Indicators

Market Signals
Indicator
CUBI
AMPH
Relative Strength Index (RSI) 68.83 46.74
Support Level $69.00 $25.20
Resistance Level $74.57 $26.50
Average True Range (ATR) 1.96 0.82
MACD 0.42 -0.17
Stochastic Oscillator 88.43 19.97

Price Performance

Historical Comparison
CUBI
AMPH

About CUBI Customers Bancorp Inc

Customers Bancorp Inc is a bank holding company engaged in banking activities. It provides financial products and services to small and middle-market businesses, not-for-profits, and consumers. The company operates in Lending Activities, Commercial Lending, Consumer Lending, Private Banking, Deposit Products, Other Funding Sources and Financial Products and Services. The majority of revenue is derived from commercial lending.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: